NCT06897540

Brief Summary

To assess the prevalence and characteristics of BE in patients suffering of chronic GERD symptoms

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
2mo left

Started Apr 2025

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress88%
Apr 2025Jul 2026

First Submitted

Initial submission to the registry

March 17, 2025

Completed
10 days until next milestone

First Posted

Study publicly available on registry

March 27, 2025

Completed
5 days until next milestone

Study Start

First participant enrolled

April 1, 2025

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2026

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2026

Expected
Last Updated

March 27, 2025

Status Verified

March 1, 2025

Enrollment Period

12 months

First QC Date

March 17, 2025

Last Update Submit

March 25, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • To assess the prevalence and characteristics of BE in patients suffering of chronic GERD symptoms.

    To assess the prevalence and characteristics of BE in patients suffering of chronic GERD symptoms. To evaluate demographic and clinical risk factors associated with BE in GERD patients. To assess the clinical features of GERD in patients who develop BE. To investigate the diagnostic methods used to detect BE in clinical settings. To assess the relationship between chronicity of GERD and development of BE.

    Assessment of patients with GERD take about 2 weeks

Study Arms (1)

Patients with GERD

OTHER

Screening for Barrett's esophagus in patients with GERD by upper endoscopy

Device: Upper endoscopy

Interventions

View mucosa of esophagus with upper endoscope

Patients with GERD

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults diagnosed with GERD based on clinical symptoms and/or 24-hour pH monitoring or esophageal manometry.
  • Patients willing to undergo endoscopic examination

You may not qualify if:

  • Patients with other esophageal diseases, such as eosinophilic esophagitis, infections, or motility disorders.
  • Patients who are unable to consent or participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Barrett Esophagus

Interventions

Gastroscopy

Condition Hierarchy (Ancestors)

Precancerous ConditionsNeoplasmsEsophageal DiseasesGastrointestinal DiseasesDigestive System Diseases

Intervention Hierarchy (Ancestors)

Endoscopy, GastrointestinalEndoscopy, Digestive SystemDiagnostic Techniques, Digestive SystemDiagnostic Techniques and ProceduresDiagnosisEndoscopyDiagnostic Techniques, SurgicalDigestive System Surgical ProceduresSurgical Procedures, OperativeMinimally Invasive Surgical Procedures

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SCREENING
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident doctor at Assiut University Hospitals

Study Record Dates

First Submitted

March 17, 2025

First Posted

March 27, 2025

Study Start

April 1, 2025

Primary Completion

March 31, 2026

Study Completion (Estimated)

July 1, 2026

Last Updated

March 27, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Only patients who will be discovered having Barrett's esophagus will their IPD ba shared